MLYNF yields 5.96% · MRK yields 2.76%● Live data
📍 MLYNF pulled ahead of the other in Year 1
Combined, MLYNF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MLYNF + MRK for your $10,000?
Malayan Banking Berhad provides commercial banking and related financial products and services for individuals, small and medium enterprises, retail and corporate customers, and financial institutions primarily in Malaysia, Singapore, and Indonesia. The company operates through three segments: Group Community Financial Services, Group Global Banking, and Group Insurance and Takaful. It offers savings and fixed deposits, and current and money market accounts; and housing and personal loans, project financing, overdrafts, and trade financing, as well as remittance service. The company also offers credit cards; bancassurance products; hire purchase, unit trust, cash management, custodian, and trustee services; and treasury activities and services, including foreign exchange, money market, derivatives, and trading of capital market. In addition, it provides investment banking and securities broking services; corporate advisory, bond and equity issuance, syndicated acquisition advisory, debt restructuring advisory, and share and futures dealings; and asset and fund management services, including a range of conventional and Islamic investment solutions. Further, the company underwrites general and life insurance businesses, offshore investment life insurance business, and general and family takaful products; and offers offshore banking, property leasing and trading, nominee, property investment, IT shared and development, financial and investment advisory, money lending, private equity investments, research, and leasing and factoring services. The company operates a network of approximately 2,200 branches in 20 countries internationally. Malayan Banking Berhad was incorporated in 1960 and is headquartered in Kuala Lumpur, Malaysia.
Full MLYNF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.